The Risk of Creating Difficult-To-Treat Psoriasis by Switching Multiple Biologic Therapies: A Case Report and Relative Considerations

Journal Title: Journal of Dermatology Research - Year 2022, Vol 3, Issue 1

Abstract

Despite the revolution represented by biologic drugs, it is safe to say that every dermatologist has known the frustrating experience of treating a “difficult” patient with psoriasis. Such patients may have been treated with numerous drugs, never achieving long-term disease control. We hereby present the case of a patient who, despite having been treated, over the course of 15 years, with 7 biologics and 3 traditional systemic agents, has never experienced lasting remission. We also discuss hypothetical reasons for these repeated treatment failures: while obesity and ANA positivity could have contributed significantly, a third, more complex, factor may be to blame. It is possible that frequently switching to the newest drug available, due to lack of other therapeutic options, interfered with the pathogenetic phenotype of the patient, and, consequently, with the response to other biologics. This disheartening and fascinating hypothesis clearly needs to be investigated, in the hope of finding solutions for all seemingly impossible-to-treat patients.

Authors and Affiliations

Martina Burlando1*, Ilaria Salvi1, Emanuele Cozzani1, Aurora Parodi1

Keywords

Related Articles

Flattened Nose Revealing Syphilitic Aortitis

Flattened nose also called syphilis nose is a deformation of the nose due to the destruction of the cartilage of the nasal septum: the lower segment of the nose collapses, undergoes recoil and retract, becoming embedded...

Rheumatoid Epidemioclinical Profile of Dermatoses in Children Aged 0 to 18 Years in the Dermatology -Venereology Department of the National Hospital and University Centre – HKM of Cotonou (Benin)

Introduction: Skin diseases are a public health problem in all developing countries. In most African countries they are dominated by infectious, immuno-allergic, inflammatory and tumourous skin diseases. So far, no stu...

Most Common Drug Eruptions by Pattern and Drug Class: A Review

Cutaneous drug reactions come in many different morphologies, distributions and severities ranging from pruritus and erythema to diffuse epidermal denudation requiring hospitalization. The wide variety of presentations a...

Clinical Efficacy and Skin Bioengineering Evaluations of a Semi-Occlusive Healing Ointment as an Adjuvant Therapy in Hand Eczema

Background: Hand Eczema (HE) is the most common skin problem during SARS-CoV-2 pandemic which has impaired quality of life, impact work ability and cause hand dysfunction. The use of Topical Corticosteroid (TCS) alone ca...

The Efficacy and Safety of Oral Propranolol in Hemangioma of PHACES Syndrome: A Case Report

PHACES syndrome is a rare condition characterized by the association of infantile hemangioma with malformations of the posterior fossa of the brain, arterial anomalies of the central nervous system, heart defects, ocular...

Download PDF file
  • EP ID EP702452
  • DOI http://dx.doi.org/10.46889/JDR.2022.3102
  • Views 55
  • Downloads 0

How To Cite

Martina Burlando1*, Ilaria Salvi1, Emanuele Cozzani1, Aurora Parodi1 (2022). The Risk of Creating Difficult-To-Treat Psoriasis by Switching Multiple Biologic Therapies: A Case Report and Relative Considerations. Journal of Dermatology Research, 3(1), -. https://europub.co.uk./articles/-A-702452